Trial of Oxaloacetate in ALS
NCT04204889
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
18
Enrollment
OTHER
Sponsor class
Conditions
ALS
Interventions
DRUG:
Oxaloacetic Acid
Sponsor
Omar Jawdat
Collaborators
[object Object]